Semaglutide is not approved to treat obstructive sleep apnea, and safety and efficacy for this condition have not been established
For Women Returning to Fitness Alternate light cycling with rest days to avoid overexertion
Most provincial formularies cover semaglutide for type 2 diabetes with prior authorization from your doctor
If approved by the FDA, lixisenatide will become the fourth GLP-1 agonist available on the market, following Victoza, Byetta, and Bydureon
Finding out whats causing the problem is the first step towards finding the right, personalised solution for you
Zepbound is FDA approved and covered by Part D for this indication, so patients with moderate to severe OSA are directed to their Part D plan rather than the Bridge